摘要
目的探讨右旋糖酐铁联合促红细胞生成素(EPO)的应用对妊娠期缺铁性贫血患者网织红细胞(RET)、铁调素-25水平的影响。方法选取2021年7月至12月上饶市人民医院收治的80例妊娠期缺铁性贫血孕妇作为研究对象,采用随机数字表法将其分为观察组(40例)和对照组(40例)。对照组患者采取EPO治疗,观察组患者则在对照组基础上增加右旋糖酐铁进行治疗。观察和比较两组患者的贫血相关指标,包括血红蛋白(Hb)、红细胞平均体积(MCV)和EPO水平;比较两组患者的血清铁有关指标,包括铁蛋白(SF)水平、铁调素-25、膜转运蛋白1(FPN1)、铁幼素(HJV)水平及可溶性转铁蛋白受体(sTfR)水平;比较两组患者的血液学指标,包括RET计数、RET比率(MFR)、未成熟RET比率(IRF)、低荧光RET比率(LFR)、血红蛋白含量(RET-He)。结果治疗前,两组患者的Hb、MCV、EPO、SF、sTfR、铁调素-25、FPN1、HJV、RET、MFR、IRF、LFR、RET-He水平比较,差异无统计学意义(P>0.05);观察组患者治疗1个月后的Hb、MCV水平高于对照组,EPO水平低于对照组,差异有统计学意义(P<0.05);观察组患者治疗1个月后的SF、铁调素-25、HJV水平高于对照组,sTfR、FPN1水平低于对照组,差异有统计学意义(P<0.05);观察组患者治疗1个月后的RET、MFR、IRF水平低于对照组,LFR、RET-He水平高于对照组,差异有统计学意义(P<0.05)。结论应用右旋糖酐铁联合EPO治疗妊娠期缺铁性贫血患者,可抑制患者RET、铁调素-25水平的异常表达,能够有效改善患者的贫血状况。
Objective To explore the application effect of Iron Dextran combined with erythropoietin(EPO)on the levels of reticulocyte(RET)and hepcidin-25 in patients with iron deficiency anemia during pregnancy.Methods A total of 80 pregnant women with iron deficiency anemia during pregnancy who were treated in Shangrao People′s Hospital between July and December 2021 were selected as the research subjects,and they were divided into observation group(40 cases)and control group(40 cases)by random number table method.The patients in the control group were treated with EPO,while the patients in the observation group were additionally given Iron Dextran on the basis of the control group.The anemia-related indicators,including hemoglobin(Hb),mean corpuscular volume(MCV)and EPO levels were observed and compared between the two groups.Serum iron related indexes,including ferritin(SF)level,hepcidin-25,membrane transporter 1(FPN1),hemojuvelin(HJV)level and soluble transferrin receptor(sTfR)level were compared between the two groups.Hematological indexes,including RET count,mature RET ratio(MFR),immature RET fraction(IRF),low fluorescence RET ratio(LFR)and hemoglobin content(RET-He)were compared between the two groups.Results Before treatment,there were no significant differences in the levels of Hb,MCV,EPO,SF,sTfR,hepcidin-25,FPN1,HJV,RET,MFR,IRF,LFR and RET-He between the two groups(P>0.05).After 1 month of treatment,the levels of Hb and MCV in the observation group were higher than those in the control group,and the level of EPO in the observation group was lower than that in the control group,and the differences were statistically significant(P<0.05).After 1 month of treatment,the levels of SF,hepcidin-25 and HJV in the observation group were higher than those in the control group,and the levels of sTfR and FPN1 in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).After 1 month of treatment,the levels of RET,MFR and IRF in the observation group were lower
作者
钟丽
张戈
ZHONG Li;ZHANG Ge(Department of Obstetrics and Gynecology,Shangrao People′s Hospital,Jiangxi Province,Shangrao334000,China)
出处
《中国当代医药》
CAS
2022年第27期104-107,共4页
China Modern Medicine
基金
江西省卫生健康委科技计划项目(202212765)。
